Experienced in Shingles

Deepali N. Kumar

Toronto, ON, CA 
Experienced in Shingles
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Deepali Kumar practices in Toronto, Canada. Kumar is rated as an Experienced expert by MediFind in the treatment of Shingles. Their top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, Severe Acute Respiratory Syndrome (SARS), Lung Transplant, and Kidney Transplant.

Their clinical research consists of co-authoring 235 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles and participated in 1 clinical trial in the study of Shingles.

Locations

Toronto, ON, Canada
Other Locations
Toronto, Canada
Edmonton, AB, Canada
Halifax, NS, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Long-term Immunogenicity Study of Herpes Zoster Subunit Vaccine (GSK1437173A) and Immunogenicity and Safety Assessment of Revaccination With Two Additional Doses in Adults With Renal Transplant From Study ZOSTER-041
Long-term Immunogenicity Study of Herpes Zoster Subunit Vaccine (GSK1437173A) and Immunogenicity and Safety Assessment of Revaccination With Two Additional Doses in Adults With Renal Transplant From Study ZOSTER-041
Enrollment Status: Completed
Publish Date: July 18, 2025
Intervention Type: Biological
Study Drug: HZ/su vaccine (GSK1437173A)
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

235 Total Publications

A Network for Advancing Prevention and Treatment of Infections Among Immunocompromised Individuals.
A Network for Advancing Prevention and Treatment of Infections Among Immunocompromised Individuals.
Journal: JAMA network open
Published: August 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kumar's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile